Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 9, 1997, Pages 2991-2995

  Petraglia, F ^a   Luisi, S ^b   Benedetto, C ^c   Zonca, M ^c   Florio, P ^b   Casarosa, E ^b   Volpe, A ^a   Bernasconi, S ^a   Genazzani, A R ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBIN; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HIGH RISK PREGNANCY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL HYPERTENSION; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; SPONTANEOUS ABORTION; THIRD TRIMESTER PREGNANCY;

ADULT; DIMERIZATION; FEMALE; FETAL GROWTH RETARDATION; HUMANS; HYPERTENSION; INHIBINS; LONGITUDINAL STUDIES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; REFERENCE VALUES;

EID: 0030885025     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.9.2991     Document Type: Article

References (37)

1. Ying S-Y. 1988 Inhibins, activins and follistatin: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev. 9:267-293.
2. Petraglia F, Garuti GC, Calzà L, et al. 1991 Inhibin subunits in human placenta: localization and messenger ribonucleic acid levels during pregnancy. Am J Obstet Gynecol. 165:750-758.
3. Petraglia F, Woodruff TK, et al. 1992 Gonadotropin-releasing hormone, inhibin, and activin in human placenta: evidence for a common cellular localization. J Clin Endocrinol Metab. 74:1184-1188.
4. deKretser DM, Foulds LM, Hancock M, Robertson DM. 1994 Partial characterisation of inhibin, activin and follistatin in the term human placenta. J Clin Endocrinol Metab. 79:502-507.
5. Yokoyama Y, Nakamura T, Nakamura R, Irahara M, Aono T, Sugino H. 1995 Identification of activins and follistatin proteins in human follicular fluid and placenta. J Clin Endocrinol Metab. 80:915-921.
6. Qu J, Thomas K. 1992 Changes in bioactive and immunoactive inhibin levels around human labor. J Clin Endocrinol Metab. 74:1290-1295.
7. Abe Y, Hasegawa Y, Miyamoto K, et al. 1990 High concentrations of plasma immunoreactive inhibin during normal pregnancy in women. J Clin Endocrinol Metab. 71:133-137.
8. Tabei T, Ochiai K, Terashima Y, Takanashi N. 1991 Serum levels of inhibin in maternal and umbilical blood during pregnancy. Am J Obstet Gynecol. 164:896-900.
9. McLachlan RI, Healy DL, Lutjen PJ, Findlay JK, deKretser DM, Burger HG. 1987 The maternal ovary is not the source of circulating inhibin levels during human pregnancy. Clin Endocrinol (Oxf). 27:663-668.
10. Khalil A, Kaufmann RC, Wortsman J, Winters SJ, Huffman DG. 1995 Inhibin in normal and abnormal pregnancy: maternal serum concentration and partial characterization. Am J Obstet Gynecol. 172:1019-1025.
11. Yohkaichiya T, Fukaya T, Hoshiai H, Yajima A, deKretser DM. 1989 Inhibin: a new circulating marker of hydatidiform mole? Br Med J. 298: 1684-1686.
12. Muttukrishna S, George L, Fowler PA, Groome NP, Knight PG. 1995 Measurement of serum concentrations of inhibin A (alpha-beta A dimer) during human pregnancy. Clin Endocrinol (Oxf). 42:391-397.
13. Groome NP, Illingworth PJ, O'Brien M, et al. 1996 Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab. 81:1401-1405.
14. Illingworth PJ, Groome NP, Duncan-Colin W, et al. 1996 Measurement of circulating inhibin forms during the establishment of pregnancy. J Clin Endocrinol Metab. 81:1471-1475.
15. Riley SC, Wathen NC, Chard T, Groome NP, Wallace EM. 1996 Inhibin in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Hum Reprod. 11:2772-2776.
16. Wallace EM, Riley SC, Crossly JA, et al. 1997 Dimeric inhibins in amniotic fluid, maternal serum, and fetal serum in human pregnancy. J Clin Endocrinol Metab. 82:218-222.
17. Parazzini F, Bortolus R, Chatenould L, et al. 1996 Risk factors for pregnancy-induced hypertension in women at high risk for the condition. Epidemiol. 7:306-308.
18. Davey DA, MacGillivray I. 1986 The classification and definition of the hypertensive disorders of pregnancy. Clin Exp Hypertes [B]. 5:97-133.
19. Pollack RN, Divon MY. 1992 Intrauterine growth retardation: definition, classification and etiology. Clin Ob Gyn. 35:99-107.
20. Petraglia F, Calza L, Garuti GC et al. 1990 Presence and synthesis of inhibin subunits in human decidua. J Clin Endocrinol Metab. 71:487-492.
21. Qu J, Thomas K. 1995 Inhibin and activin production in human placenta. Endocr Rev. 16:485-507.
22. Petraglia F, Garg S, Florio P, et al. 1993 Activin A and activin B measured in maternal serum, cord blood serum and in amniotic fluid during human pregnancy. Endoc J. 1:323-328.
23. Muttukrishna S, Fowler PA, Goerge L, Groome NP, Knight PG. 1996 Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. J Clin Endocrinol Metab. 81:3328-3334.
24. Sakamoto Y, Shintani Y, Harada K, Abe M, Shitsukawa K, Saito S. 1996 Determination of free follistatin levels in sera of normal subjects and patients with various diseases. Eur J Endocrinol. 135:345-51.
25. Shimonaka M, Inouye S, Shimasaki S, Ling N. 1991 Follistatin binds to both activin and inhibin through the common β-subunit. Endocrinology. 128:3313-3315.
26. Robertson DM, H, Sullivan J, Watson M, Cahir N. 1995 Inhibin forms in human plasma. J Endocrinol. 144:261-269.
27. Yohkaichiya T, Poison DW, Hughes EG, et al. 1993 Serum immunoactive inhibin levels in early pregnancy after in vitro fertilization and embryo transfer. Fertil Steril. 59:1081-1089.
28. Norman RJ, McLoughlin JW, Borthwick GM, et al. 1993 Inhibin and relaxin concentrations in early singleton, multiple and failing pregnancy: relationship to gonadotnipin and steroid profiles. Fertil Steril. 59:130-137.
29. Petraglia F, Aguzzoli L, Gallinelli A, Florio P, Zonca M, Benedetto C, Woodruff K. 1995 Hypertension in pregnancy: changes in activin A maternal serum concentration. Placenta. 16:447-454.
30. Kinsely D.M. 1994 The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8:133-146.
31. Massague J. 1986 The TGF-B family of growth and differentiation factors. Cell. 49:237-439.
32. Sperling MA. 1994 Carbohydrate metabolism: insulin and glucagon. In: Tulchinsky D, Little BA (eds) (Maternal-Fetal Endocrinology. Philadelphia: VVB Saunders Co.; 15-32.
33. Lassare C, Hardouin S, Daffos F, et al. 1991 Serum insulin-like growth factor and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res. 29:219-225.
34. Fant M, Safalia C, Baxter RC, et al. 1993 Circulating levels of IGFs and IGF binding proteins in human cord serum: relationships to intrauterine growth. Regul Peptides. 48:29-39.
35. Langford K, Blum W, Nicolaides K, et al. 1994 The pathophysiology of the insulin-like growth factor axis in fetal growth failure: a basis for programming by undernutrition? Eur J Clin Invest. 24:851-856.
36. Spellacy WN, Buhi WC, McCreary SA. 1974 Measurement of human placental lactogen in the last half of normal and complicated pregnancies. Am J Obstet Gynecol. 43:306-310.
37. Petraglia F, Florio P, Nappi C, Genazzani AR. 1996 Peptide signaling in human placenta and membranes: automne, paracrine, and endocrine mechanisms. Endocr Rev. 17:156-186.